Evotec And The Mark Foundation For Cancer Research Announce Strategic Collaboration In Immuno-Oncology
EVOTEC AND THE MARK FOUNDATION FORM FIRST COLLABORATION TOGETHER TO ADVANCE ONCOLOGY ASSETS BASED ON EVOTEC'S NEW ALLOSTERIC INHIBITOR PLATFORM...
News
1155176 B.C. LTD. Announces Upcoming Name Change and Consolidation Effective March 27, 2019
VANCOUVER, BC / ACCESSWIRE / March 25, 2019 / 1155176 B.C. LTD. ("176" or the "Company") is pleased to announce...
TRIGR Therapeutics Completes $14 Million Seed Round and Provides Phase 1a Clinical Update on its Lead Bispecific Oncology Candidate, TR009
IRVINE, CA / ACCESSWIRE / March 25, 2019 / TRIGR Therapeutics, Inc. (''TRIGR''), a newly formed privately held company focused...
CorMedix Confirms Previously Announced One-For-Five Reverse Stock Split
BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 25, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on...
GeneNews Closes First Tranche of $1.0 Million Strategic Private Placement
TORONTO, ON / ACCESSWIRE / March 25, 2019 / GeneNews Limited (TSX: GEN) ("GeneNews" or the "Company") today announced the...
Novus Reports Record Year 2018 Results
- Insurance Broker Participation, Provider Engagement - Drive Growth For 10th Consecutive Quarters MIAMI, FL / ACCESSWIRE / March 25,...
Hong Kong Chiropractors Find a Solution to Lower Back Pain
BERLIN, GERMANY / ACCESSWIRE / March 25, 2019 / Neck and back pain become an enormous international health crisis. The...
Ozop Surgical Corp to Present at the Spring Investor Summit on April 1st and 2nd in New York City at the Essex House
WEST PALM BEACH, FL / ACCESSWIRE / March 25, 2019 / Ozop Surgical Corp. (OTCQB: OZSC), a provider of premium...
Alimera Sciences Announces Approval Received in the Mutual Recognition Procedure for New Indication for ILUVIEN(R) in Europe
- Indication for treatment of non-infectious posterior uveitis further supports the uniqueness of ILUVIEN to consistently and continuously deliver treatment...
International Cannabrands Signs Distribution Deal for CBD Products
DENVER, CO / ACCESSWIRE / March 25, 2019 / International Cannabrands Inc. (CSE: JUJU) (the "Company") is pleased to announce...
NanoVibronix Announces Reimbursement Approvals for PainShield(R) in the U.S.
Reimbursement aligned with AHIP and CMS initiatives to help combat the opioid epidemic ELMSFORD, NY / ACCESSWIRE / March 25,...
Oryzon to Present at Upcoming International Conferences
13th Annual International Partnering Conference BIO-Europe Spring VIENNA 14th International Conference on Alzheimer's and Parkinson's Diseases (ADPD2019) LISBON MADRID, SPAIN...
WNDM Medical Inc. Announces Planned Reverse Stock Split and Company Name Change to Sanara MedTech Inc.
FORT WORTH, TX / ACCESSWIRE / March 25, 2019 / WNDM Medical Inc. (OTCQB: WNDM) Based in Fort Worth, Texas,...
Heads Up Checkup, Inc. to Present at the 146th NIBA Investment Conference
ANAHEIM HILLS, CA / ACCESSWIRE / March 25, 2019 / Heads Up Checkup, Inc., an emerging SAAS provider of mental...
Atlantic Weedboard to Present at the 146th NIBA Investment Conference
New York, NY / ACCESSWIRE / March 25, 2019 / Atlantic WeedBoard (www.atlanticWeedBoard.com), a newly formed information center for the...
Global Health & Pharma (”GHP”) Recognises InnerScope Hearing Technologies (OTCQB: INND) In the 2019 Biotechnology Awards Winners
UNITED KINGDOM / ACCESSWIRE / March 25, 2019 / GHP Magazine has awarded InnerScope Hearing Technologies, ("InnerScope") Best Hearing Aid...
Adial Pharmaceuticals Announces Filing to Update the Prior Registration Statement Registering the Shares Underlying the ADILW Warrants
CHARLOTTESVILLE, VA / ACCESSWIRE / March 25, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused...
AsclepiX Therapeutics, Inc. Strengthens Board of Directors, Welcomes Steven Altschuler, MD
AsclepiX Therapeutics, Inc., a biopharmaceutical company focused on developing novel peptide therapies, including AXT107 for retinal disease and novel peptides...
Glycotope Expands Phase Ib Trial of Combination of Proprietary Anti-Tumor Antibodies to Include Marketed Anti-Tumor Antibodies
- GATTO Study Extension to Evaluate Gatipotuzumab and Tomuzotuximab or marketed anti-EGFR Monoclonal Antibody Drugs in refractory metastatic solid tumors...
Kadmon Announces Susan Wiviott to Step Down from Board of Directors
NEW YORK, NY / ACCESSWIRE / March 22, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Susan Wiviott...